These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 38974244)

  • 1.
    Fanale D; Corsini LR; Brando C; Randazzo U; Bono M; Pedone E; Perez A; Sciacchitano R; Cancelliere D; Piraino P; Giurintano A; Bazan Russo TD; Ferraro P; Rinaldi G; Spinnato V; Gennusa V; Pernice G; Vieni S; Pantuso G; Russo A; Bazan V
    Front Oncol; 2024; 14():1414343. PubMed ID: 38974244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hereditary Breast and Ovarian Cancer in Families from Southern Italy (Sicily)-Prevalence and Geographic Distribution of Pathogenic Variants in
    Incorvaia L; Fanale D; Badalamenti G; Bono M; Calò V; Cancelliere D; Castiglia M; Fiorino A; Pivetti A; Barraco N; Cutaia S; Russo A; Bazan V
    Cancers (Basel); 2020 May; 12(5):. PubMed ID: 32380732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing.
    Tuncer SB; Celik B; Erciyas SK; Erdogan OS; Gültaslar BK; Odemis DA; Avsar M; Sen F; Saip PM; Yazici H
    Pathol Res Pract; 2024 Feb; 254():155075. PubMed ID: 38219492
    [TBL] [Abstract][Full Text] [Related]  

  • 4.
    Incorvaia L; Fanale D; Bono M; Calò V; Fiorino A; Brando C; Corsini LR; Cutaia S; Cancelliere D; Pivetti A; Filorizzo C; La Mantia M; Barraco N; Cusenza S; Badalamenti G; Russo A; Bazan V
    Ther Adv Med Oncol; 2020; 12():1758835920975326. PubMed ID: 33403015
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence and Spectrum of Germline
    Fanale D; Fiorino A; Incorvaia L; Dimino A; Filorizzo C; Bono M; Cancelliere D; Calò V; Brando C; Corsini LR; Sciacchitano R; Magrin L; Pivetti A; Pedone E; Madonia G; Cucinella A; Badalamenti G; Russo A; Bazan V
    Front Oncol; 2021; 11():682445. PubMed ID: 34178674
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased Risk of Hereditary Prostate Cancer in Italian Families with Hereditary Breast and Ovarian Cancer Syndrome Harboring Mutations in
    D'Elia G; Caliendo G; Tzioni MM; Albanese L; Passariello L; Molinari AM; Vietri MT
    Genes (Basel); 2022 Sep; 13(10):. PubMed ID: 36292577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of hereditary breast and ovarian cancer syndrome and sporadic ovarian cancer in ovarian cancer BRCA mutations].
    Duan RR; Sun LX; Zhao HW
    Zhonghua Fu Chan Ke Za Zhi; 2021 Nov; 56(11):788-795. PubMed ID: 34823292
    [No Abstract]   [Full Text] [Related]  

  • 8. Using Portuguese BRCA pathogenic variation as a model to study the impact of human admixture on human health.
    Andaluz S; Zhao B; Sinha S; Lagniton PNP; Costa DA; Ding X; Brito M; Wang SM
    BMC Genomics; 2024 Apr; 25(1):416. PubMed ID: 38671360
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of a BRCA2 Pathogenic Variant in Hereditary-Breast-and-Ovarian-Cancer-Syndrome Families with Increased Risk of Pancreatic Cancer in a Restricted Italian Area.
    Zampiga V; Cangini I; Bandini E; Azzali I; Ravegnani M; Ravaioli A; Mancini S; Tebaldi M; Tedaldi G; Pirini F; Veneroni L; Frassineti GL; Falcini F; Danesi R; Calistri D; Arcangeli V
    Cancers (Basel); 2023 Apr; 15(7):. PubMed ID: 37046793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and Spectrum of
    Foglietta J; Ludovini V; Bianconi F; Pistola L; Reda MS; Al-Refaie A; Tofanetti FR; Mosconi A; Minenza E; Anastasi P; Molica C; Stracci F; Roila F
    Genes (Basel); 2020 Aug; 11(8):. PubMed ID: 32806537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Analysis of pathogenic variants in BRCA1 and BRCA2 genes using next-generation sequencing in women with triple negative breast cancer from South India.
    Rajagopal T; Seshachalam A; Jothi A; Rathnam KK; Talluri S; Venkatabalasubranian S; Dunna NR
    Mol Biol Rep; 2022 Apr; 49(4):3025-3032. PubMed ID: 35020120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of Cancer Predisposition Germline Variants in Male Breast Cancer Patients: Results of the German Consortium for Hereditary Breast and Ovarian Cancer.
    Rolfes M; Borde J; Möllenhoff K; Kayali M; Ernst C; Gehrig A; Sutter C; Ramser J; Niederacher D; Horváth J; Arnold N; Meindl A; Auber B; Rump A; Wang-Gohrke S; Ritter J; Hentschel J; Thiele H; Altmüller J; Nürnberg P; Rhiem K; Engel C; Wappenschmidt B; Schmutzler RK; Hahnen E; Hauke J
    Cancers (Basel); 2022 Jul; 14(13):. PubMed ID: 35805063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of ovarian and breast cancer risk in non-BRCA HBOC pathogenic variant carriers in a large California health care system.
    Powell CB; Laurent C; Garcia C; Hoodfar E; Karlea A; Kobelka C; Lee J; Roh J; Kushi LH
    Gynecol Oncol; 2022 Dec; 167(3):467-475. PubMed ID: 36220669
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Frequency of germline pathogenic variants in breast cancer predisposition genes among young Turkish breast cancer patients.
    Isiklar AD; Aliyeva L; Yesilyurt A; Soyder A; Basaran G
    Breast Cancer Res Treat; 2023 Nov; 202(2):297-304. PubMed ID: 37615792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of specific and recurrent/founder pathogenic variants in BRCA genes in breast and ovarian cancer in North Africa.
    ElBiad O; Laraqui A; El Boukhrissi F; Mounjid C; Lamsisi M; Bajjou T; Elannaz H; Lahlou AI; Kouach J; Benchekroune K; Oukabli M; Chahdi H; Ennaji MM; Tanz R; Sbitti Y; Ichou M; Ennibi K; Badaoui B; Sekhsokh Y
    BMC Cancer; 2022 Feb; 22(1):208. PubMed ID: 35216584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of BRCA Tumour Testing in an Integrated Molecular Tumour Board Multidisciplinary Model.
    Azzollini J; Vingiani A; Agnelli L; Tamborini E; Perrone F; Conca E; Capone I; Busico A; Peissel B; Rosina E; Ducceschi M; Mantiero M; Lopez S; Raspagliesi F; Niger M; Duca M; Damian S; Proto C; de Braud F; Pruneri G; Manoukian S
    Front Oncol; 2022; 12():857515. PubMed ID: 35463374
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the pathogenic variants of BRCA1 and BRCA2 using next-generation sequencing in women with familial breast cancer: a case-control study.
    Zayas-Villanueva OA; Campos-Acevedo LD; Lugo-Trampe JJ; Hernández-Barajas D; González-Guerrero JF; Noriega-Iriondo MF; Ramírez-Sánchez IA; Martínez-de-Villarreal LE
    BMC Cancer; 2019 Jul; 19(1):722. PubMed ID: 31331294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High prevalence of deleterious BRCA1 and BRCA2 germline mutations in arab breast and ovarian cancer patients.
    Alhuqail AJ; Alzahrani A; Almubarak H; Al-Qadheeb S; Alghofaili L; Almoghrabi N; Alhussaini H; Park BH; Colak D; Karakas B
    Breast Cancer Res Treat; 2018 Apr; 168(3):695-702. PubMed ID: 29297111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extended genetic analysis and tumor characteristics in over 4600 women with suspected hereditary breast and ovarian cancer.
    Öfverholm A; Törngren T; Rosén A; Arver B; Einbeigi Z; Haraldsson K; Ståhlbom AK; Kuchinskaya E; Lindblom A; Melin B; Paulsson-Karlsson Y; Stenmark-Askmalm M; Tham E; von Wachenfeldt A; Kvist A; Borg Å; Ehrencrona H
    BMC Cancer; 2023 Aug; 23(1):738. PubMed ID: 37563628
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.